Study Zh Nevrol Psikhiatr Im S S Korsakova 1996

The use of hyperbaric oxygenation in treating mental patients resistant to psychopharmacotherapy

Kut'ko I, Spirina I, Andreĭko M, Efimov O — Zh Nevrol Psikhiatr Im S S Korsakova, 1996

View Original on PubMed PMID 9012254

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers studied if hyperbaric oxygen therapy could help patients with schizophrenia or vascular mental disorders who were not responding to standard psychiatric medications.

What They Found

A positive clinical effect was observed in 72.5% of all patients, including 67.4% of schizophrenic patients and 77.4% of patients with vascular mental disorders. The study concluded that HBOT helped shorten hospital stays and improved both clinical and social outcomes for these patients.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This older observational study from 1996 does not provide details on its design, specific HBOT protocols, or long-term patient outcomes.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type	Study
Category	Neurological
Source	Pubmed
PubMed ID	9012254
Year Published	1996
Journal	Zh Nevrol Psikhiatr Im S S Korsakova
MeSH Terms	Adolescent; Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Drug Resistance; Female; Humans; Hyperbaric Oxygenation; Male; Mental Disorders; Middle Aged; Neurocognitive Disorders; Prognosis; Psychopathology; Psychotropic Drugs; Schizophrenia; Schizophrenic Psychology

Related Research

PLoS ONE | 2013 RCT

Hyperbaric oxygen induces late neuroplasticity in post stroke patients--randomized, prospective trial.

Efrati S, Fishlev G, Bechor Y, et al.

J Neurotrauma | 2018 Systematic Review

Hyperbaric oxygen therapy in the treatment of acute severe traumatic brain injury: a systematic review

Daly S, Thorpe M, Rockswold S, et al.

J Neurotrauma | 2012 Pilot Study

A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and PTSD

Harch PG, Andrews SR, Fogarty EF, et al.

Scientific Reports | 2022 RCT

Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.

Hadanny A, Zilberman-Itskovich S, Catalogna M, et al.

PLoS ONE | 2013 RCT

Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury — randomized prospective trial

Boussi-Gross R, Golan H, Fishlev G, et al.

See all Neurological research

View on PubMed Back to Research Library

Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology